Don't forget, the main success here is not the production at Nottingham, but the deals that are done with large companies. It all takes time, even though it's frustrating, hold the faith.
Dr Micho, Stop being so negative. Covid is an important intervention in everyone's life and for me to be able to get some to help protect my elderely father gives me satisfaction. It's not just about the sp here, whilst we all want to make money, many are interested in the product itself.
Good post. I think the main turning point will be licencing the mask out, or crop studies. The small machine they have purchased will only make a small amount compared to the overall potential here. The machine, however, does provide proof of concept and an important step. Roll on the deals.
Goldtrig, Can you stay off the drugs today. You managed to constantly upset and ruin the LSE board of 3 companies yesterday. No-one wants to hear your perpetual negative musings. In fact, sod it, it's green box time.
Like I said a while ago, lets go Stateside and give a large two fingers to BJ and his upper-crust cronies. They're just lining their own pockets and fellow mason's.
Andip, You're a bit misleading. Yes m/c is running at a rate of 58%, the capacity is related to the maximum it can produce, i.e running 24/7 is when it can achieve max capacity. What I'm trying to say is capacity is not related to rate but TOTAL volume it can produce
Great RNS, just that timelines longer than I thought. Like this bit "Importantly, the Paraytec team is also exploring its use for rapid detection and identification of bacterial and viral pathogens present in patients with sepsis, a global killer of over 11 million people per year."